Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.
2.

Review of a randomized trial comparing 2 cerumenolytic agents.

Lemon HM, Mazyck-Brown J, Cancellaro TA, Darden PM, Basco WT Jr.

Arch Pediatr Adolesc Med. 2003 Dec;157(12):1181-3. No abstract available.

PMID:
14662570
3.

Re: ethnic differences in estrogen metabolism in healthy women.

Lemon HM, Rodriguez-Sierra JF.

J Natl Cancer Inst. 1997 Nov 5;89(21):1626-8. No abstract available.

PMID:
9362164
4.

Cancers related to contraceptive use.

Rettig BA, Lemon HM.

Br J Cancer. 1996 Nov;74(9):1509-10. No abstract available.

5.

Younger women with breast carcinoma have a poorer prognosis than older women.

Lemon HM, Rodriguez-Sierra JF.

Cancer. 1996 Oct 1;78(7):1517-8. No abstract available.

PMID:
8839561
6.

Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.

Lemon HM, Rodriguez-Sierra JF.

Nebr Med J. 1996 Apr;81(4):110-5.

PMID:
8628449
7.

Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.

Lemon HM, Rodriguez-Sierra JF.

Nebr Med J. 1996 Mar;81(3):73-8. Corrected and republished in: Nebr Med J. 1996 Apr;81(4):110-5.

PMID:
8907825
8.

Decreased cardiovascular disease and increasing cancer.

Lemon HM.

JAMA. 1994 Jul 20;272(3):199; author reply 199-200. No abstract available.

PMID:
8022031
9.

Re: "Breast cancer and cigarette smoking: a hypothesis".

Lemon HM.

Am J Epidemiol. 1992 May 15;135(10):1184-5. No abstract available.

PMID:
1632427
10.

Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer.

Lemon HM, Heidel JW, Rodriguez-Sierra JF.

Cancer. 1992 Jan 15;69(2):457-65.

PMID:
1309434
11.

A method for estimating catechol estrogen metabolism from excretion of noncatechol estrogens.

Lemon HM, Heidel JW, Rodriguez-Sierra JF.

Cancer. 1991 Jul 15;68(2):444-50.

PMID:
1649001
12.

Breast cancer genetics.

Lemon HM.

Lancet. 1991 Apr 27;337(8748):1039. No abstract available.

PMID:
1673189
13.

Inhibition of radiogenic mammary carcinoma in rats by estriol or tamoxifen.

Lemon HM, Kumar PF, Peterson C, Rodriguez-Sierra JF, Abbo KM.

Cancer. 1989 May 1;63(9):1685-92.

PMID:
2702580
14.

Antimammary carcinogenic activity of 17-alpha-ethinyl estriol.

Lemon HM.

Cancer. 1987 Dec 15;60(12):2873-81.

PMID:
3119187
15.

Estrogens and risk of breast cancer.

Lemon HM, Foley JF.

JAMA. 1987 Apr 24;257(16):2165-6. No abstract available.

PMID:
3560394
16.

Predicting response to tamoxifen in metastatic breast cancer.

Connor JL, Foley JF, Lemon HM.

Nebr Med J. 1986 Dec;71(12):422-6. No abstract available.

PMID:
3796760
17.

Breast cancer and the use of oral contraceptives.

Lemon HM, Lynch HT.

JAMA. 1986 Nov 7;256(17):2346. No abstract available.

PMID:
3773140
18.

Progress in prevention, detection and treatment of cancer.

Lemon HM.

Nebr Med J. 1984 Oct;69(10):321-4. No abstract available.

PMID:
6493388
19.
20.

Chronic phenytoin administration and the hepatic mixed function oxidase system in female rats.

Heinicke RJ, Stohs SJ, Al-Turk W, Lemon HM.

Gen Pharmacol. 1984;15(2):85-9.

PMID:
6714646
21.
22.
23.

Therapy of malignant APUD cell tumors. Effectiveness of DTIC.

Kessinger A, Foley JF, Lemon HM.

Cancer. 1983 Mar 1;51(5):790-4.

PMID:
6295614
24.

Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicity.

Kessinger A, Lemon HM, Foley JF.

Am J Clin Oncol. 1983 Feb;6(1):113-5. No abstract available.

PMID:
6837502
25.

Detection of metastatic liver disease. Use of liver scans and biochemical liver tests.

Tempero MA, Petersen RJ, Zetterman RK, Lemon HM, Gurney J.

JAMA. 1982 Sep 17;248(11):1329-32.

PMID:
7109154
26.

In vitro production of estriol from four steroid precursors by rabbit tissues.

Padron VA, Lemon HM, Stohs SJ.

Horm Metab Res. 1982 Jun;14(6):323-6.

PMID:
7118056
27.

VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.

Tempero M, Kessinger A, Lemon HM.

Cancer Clin Trials. 1981;4(2):155-7. No abstract available.

PMID:
6265110
28.
30.

Treatment of breast cancer with oral four-drug chemotherapy.

Foley JF, Kessinger MA, Lemon HM.

J Surg Oncol. 1980;14(1):67-72.

PMID:
6991822
31.

My specialty: oncology.

Lemon HM.

Nebr Med J. 1979 Aug;64(8):259. No abstract available.

PMID:
384277
32.

VM-26 as a second drug in the treatment of brain gliomas.

Kessinger A, Lemon HM, Foley JF.

Cancer Treat Rep. 1979 Mar;63(3):511-2.

PMID:
427830
33.

Five-day continuous infusion of 5-fluorouracil for advanced colorectal, gastric, and pancreatic adenocarcinoma.

Hartman HA Jr, Kessinger A, Lemon HM, Foley JF.

J Surg Oncol. 1979;11(3):227-38.

PMID:
459516
34.
35.

Hormonal therapy of breast cancer.

Lemon HM.

Ann Intern Med. 1978 Sep;89(3):422-3. No abstract available.

PMID:
686558
36.

Small cell undifferentiated bronchogenic carcinoma: current status with emphasis upon the role of chemotherapy.

Johnson PS, Foley JF, Kessinger A, Lemon HM.

J Surg Oncol. 1978;10(6):549-57.

PMID:
215847
37.

Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.

Kessinger A, Lemon HM, Foley JF.

J Surg Oncol. 1978;10(6):543-7.

PMID:
215846
38.

Experimental basis for multiple primary carcinogenesis by sex hormones: a review.

Lemon HM.

Cancer. 1977 Oct;40(4 Suppl):1825-32. Review. No abstract available.

PMID:
332331
39.

Use of DTIC in the malignant carcinoid syndrome.

Kessinger A, Foley JF, Lemon HM.

Cancer Treat Rep. 1977 Jan-Feb;61(1):101-2. No abstract available.

PMID:
861955
40.

The therapeutic dilemma of carcinomas of unknown origin.

Feleppa VB, Lemon HM.

J Surg Oncol. 1977;9(5):453-62.

PMID:
592844
41.

The glucagonoma syndrome and its management.

Kessinger A, Lemon HM, Foley JF.

J Surg Oncol. 1977;9(5):419-24.

PMID:
201809
42.
43.

Quadrichemotherapy for advanced ovarian carcinoma.

Kessinger A, Foley JF, Lemon HM.

Obstet Gynecol. 1976 Aug;48(2):134-6.

PMID:
940644
44.

Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.

Valverde I, Lemon HM, Kessinger A, Unger RH.

J Clin Endocrinol Metab. 1976 May;42(5):804-8.

PMID:
178682
45.

Chemotherapy of non-resectable soft tissue sarcomas.

Kessinger A, Foley JF, Lemon HM.

Nebr Med J. 1975 May;60(5):147-153. No abstract available.

PMID:
1128734
46.

Letter: Factors that influence mammary carcinogenesis.

Lemon HM.

N Engl J Med. 1975 May 1;292(18):974-5. No abstract available.

PMID:
1117930
48.

Summary and recommendations of the workshop on breast cancer.

Lemon HM, Thiessen EU.

Cancer. 1974 Jun;33(6):1740-3. No abstract available.

PMID:
4835168
49.
50.

Epidemiology of leukemia-lymphoma in mid-Nebraska. 3.

Caldwell GG, Rosenlof RC, Lemon HM, Bailey RE, Chin TD.

Nebr Med J. 1973 Sep;58(9):338-40. No abstract available.

PMID:
4732406

Supplemental Content

Loading ...
Support Center